Compass Therapeutics, Inc. (CMPX)
0.8701
-0.03
(-2.97%)
USD |
NASDAQ |
Oct 16, 12:42
Compass Therapeutics SG&A Expense (TTM) : 21.62M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.62M |
| March 31, 2026 | 18.87M |
| December 31, 2025 | 16.87M |
| September 30, 2025 | 16.09M |
| June 30, 2025 | 16.72M |
| March 31, 2025 | 16.80M |
| December 31, 2024 | 15.13M |
| September 30, 2024 | 14.56M |
| June 30, 2024 | 14.03M |
| March 31, 2024 | 12.42M |
| December 31, 2023 | 12.25M |
| September 30, 2023 | 12.24M |
| June 30, 2023 | 11.95M |
| March 31, 2023 | 11.96M |
| December 31, 2022 | 11.66M |
| Date | Value |
|---|---|
| September 30, 2022 | 12.13M |
| June 30, 2022 | 12.02M |
| March 31, 2022 | 11.06M |
| December 31, 2021 | 10.93M |
| September 30, 2021 | 11.04M |
| June 30, 2021 | 13.64M |
| March 31, 2021 | 13.56M |
| December 31, 2020 | 13.18M |
| September 30, 2020 | 12.74M |
| June 30, 2020 | 9.848M |
| March 31, 2020 | 11.05M |
| December 31, 2019 | 12.14M |
| September 30, 2019 | 9.039M |
| June 30, 2019 | 6.635M |
| March 31, 2019 | 3.351M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Viking Therapeutics, Inc. | 50.70M |
| Capricor Therapeutics, Inc. | 35.43M |
| Ardelyx, Inc. | 373.73M |
| Biomea Fusion, Inc. | 15.08M |
| ARS Pharmaceuticals, Inc. | 284.49M |